Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1936340

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1936340

GABA Supplements Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
PDF & Excel (Multi User License)
USD 7295
PDF & Excel (Corporate User License)
USD 8495

Add to Cart

Persistence Market Research has recently released a comprehensive report on the worldwide market for GABA supplements. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global GABA supplements market from 2025 to 2032.

Key Insights:

  • GABA Supplements Market Size (2025E): US$ 48.5 Million
  • Projected Market Value (2032F): US$ 71.0 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.6%

GABA Supplements Market - Report Scope:

Gamma-Aminobutyric Acid (GABA) supplements play an important role in supporting neurological health by acting as inhibitory neurotransmitters that help regulate nerve activity in the brain. These supplements are commonly used to promote relaxation, reduce stress and anxiety, improve sleep quality, and support mood balance. The GABA supplements market caters to a broad consumer base, including individuals seeking stress management, mental wellness, and sleep support solutions. Products are available in various forms such as capsules, tablets, powders, and gummies, and are distributed through online platforms, pharmacies, health food stores, and specialty wellness retailers. Market growth is supported by increasing awareness of mental health, rising demand for natural and dietary supplements, and a growing preference for preventive healthcare solutions.

Market Growth Drivers:

The global GABA supplements market is driven by rising prevalence of stress-related disorders, anxiety, and sleep disturbances across diverse age groups. Increasing consumer awareness regarding the benefits of neurotransmitter support supplements and the growing adoption of natural and plant-based wellness products further accelerate market growth. Lifestyle changes, long working hours, and heightened mental health concerns have amplified demand for supplements that support relaxation and cognitive balance. Additionally, expansion of e-commerce channels, social media marketing, and endorsements by health practitioners and wellness influencers contribute to increased product visibility and consumer adoption.

Market Restraints:

Despite positive growth prospects, the GABA supplements market faces challenges related to regulatory scrutiny, product efficacy concerns, and variability in consumer response. Dietary supplement regulations differ significantly across regions, creating compliance challenges for manufacturers. Limited clinical evidence supporting the bioavailability of orally administered GABA and skepticism among certain healthcare professionals may also restrain market expansion. Furthermore, price sensitivity among consumers and the availability of alternative stress-relief supplements and functional foods pose competitive pressures within the market.

Market Opportunities:

The GABA supplements market presents notable growth opportunities through product innovation, formulation advancements, and expansion into emerging markets. Development of combination supplements incorporating GABA with magnesium, L-theanine, melatonin, or herbal extracts enhances product effectiveness and consumer appeal. Increasing focus on personalized nutrition, clean-label products, and vegan or allergen-free formulations further broadens market potential. Strategic collaborations, investment in clinical research, and targeted marketing toward aging populations and working professionals are expected to unlock new growth avenues and strengthen brand positioning.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the GABA supplements market globally?
  • Which product forms and distribution channels are contributing most to market expansion?
  • How are formulation innovations influencing consumer preferences in the GABA supplements market?
  • Who are the key players operating in the GABA supplements market, and what strategies are they adopting to remain competitive?
  • What are the emerging trends and future prospects in the global GABA supplements market?

Competitive Intelligence and Business Strategy:

Leading players in the global GABA supplements market focus on product quality, transparency, and brand trust to strengthen their competitive positioning. Companies invest in research and development to enhance bioavailability, improve formulations, and introduce synergistic blends targeting stress, sleep, and cognitive health. Strategic initiatives include expanding online presence, leveraging direct-to-consumer sales models, and obtaining third-party certifications to reinforce product credibility. Emphasis on consumer education, clean labeling, and sustainable sourcing further supports long-term market growth in the evolving dietary supplements landscape.

Key Companies Profiled:

  • Now Foods
  • Horbaach
  • Pure Encapsulations
  • Thorne
  • Vitanica
  • Nutrabio
  • Country Life
  • Integrative Therapeutics
  • Solgar
  • Nusa Pure

GABA Supplements Market Research Segmentation:

By Form:

  • Capsules
  • Lozenges
  • Powder
  • Gummies

By Distribution Channel:

  • Online Stores
  • Pharmacies
  • Supermarkets
  • Others
Product Code: PMRREP33376

Table of Contents

1. Executive Summary

  • 1.1. Global GABA Supplements Market Snapshot 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Industry Developments and Key Market Events
  • 1.5. Demand Side and Supply Side Analysis
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definitions
  • 2.2. Value Chain Analysis
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Outlook
    • 2.3.2. Global GDP Outlook
    • 2.3.3. Global economic Growth Forecast
    • 2.3.4. Global Urbanization Growth
    • 2.3.5. Other Macro-economic Factors
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. COVID-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter's Five Forces Analysis
  • 2.8. Geopolitical Tensions: Market Impact
  • 2.9. Regulatory and Technology Landscape

3. Market Dynamics

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunities
  • 3.4. Trends

4. Price Trend Analysis, 2019-2032

  • 4.1. Region-wise Price Analysis
  • 4.2. Price by Segments
  • 4.3. Price Impact Factors

5. Global GABA Supplements Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 5.1. Key Highlights
  • 5.2. Global GABA Supplements Market Outlook: Form
    • 5.2.1. Introduction/Key Findings
    • 5.2.2. Historical Market Size (US$ Mn) Analysis by Form, 2019-2024
    • 5.2.3. Current Market Size (US$ Mn) Forecast, by Form, 2025-2032
      • 5.2.3.1. Capsules
      • 5.2.3.2. Lozenges
      • 5.2.3.3. Powder
      • 5.2.3.4. Gummies
    • 5.2.4. Market Attractiveness Analysis: Form
  • 5.3. Global GABA Supplements Market Outlook: Distribution Channel
    • 5.3.1. Introduction/Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2019-2024
    • 5.3.3. Current Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
      • 5.3.3.1. Online Stores
      • 5.3.3.2. Pharmacies
      • 5.3.3.3. Supermarkets
      • 5.3.3.4. Others
    • 5.3.4. Market Attractiveness Analysis: Distribution Channel

6. Global GABA Supplements Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
  • 6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia & Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America GABA Supplements Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. North America Market Size (US$ Mn) Forecast, by Form, 2025-2032
    • 7.4.1. Capsules
    • 7.4.2. Lozenges
    • 7.4.3. Powder
    • 7.4.4. Gummies
  • 7.5. North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
    • 7.5.1. Online Stores
    • 7.5.2. Pharmacies
    • 7.5.3. Supermarkets
    • 7.5.4. Others

8. Europe GABA Supplements Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. Italy
    • 8.3.3. France
    • 8.3.4. U.K.
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Rest of Europe
  • 8.4. Europe Market Size (US$ Mn) Forecast, by Form, 2025-2032
    • 8.4.1. Capsules
    • 8.4.2. Lozenges
    • 8.4.3. Powder
    • 8.4.4. Gummies
  • 8.5. Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
    • 8.5.1. Online Stores
    • 8.5.2. Pharmacies
    • 8.5.3. Supermarkets
    • 8.5.4. Others

9. East Asia GABA Supplements Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. East Asia Market Size (US$ Mn) Forecast, by Form, 2025-2032
    • 9.4.1. Capsules
    • 9.4.2. Lozenges
    • 9.4.3. Powder
    • 9.4.4. Gummies
  • 9.5. East Asia Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
    • 9.5.1. Online Stores
    • 9.5.2. Pharmacies
    • 9.5.3. Supermarkets
    • 9.5.4. Others

10. South Asia & Oceania GABA Supplements Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of SAO
  • 10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Form, 2025-2032
    • 10.4.1. Capsules
    • 10.4.2. Lozenges
    • 10.4.3. Powder
    • 10.4.4. Gummies
  • 10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
    • 10.5.1. Online Stores
    • 10.5.2. Pharmacies
    • 10.5.3. Supermarkets
    • 10.5.4. Others

11. Latin America GABA Supplements Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of LATAM
  • 11.4. Latin America Market Size (US$ Mn) Forecast, by Form, 2025-2032
    • 11.4.1. Capsules
    • 11.4.2. Lozenges
    • 11.4.3. Powder
    • 11.4.4. Gummies
  • 11.5. Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
    • 11.5.1. Online Stores
    • 11.5.2. Pharmacies
    • 11.5.3. Supermarkets
    • 11.5.4. Others

12. Middle East & Africa GABA Supplements Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Northern Africa
    • 12.3.4. Rest of MEA
  • 12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Form, 2025-2032
    • 12.4.1. Capsules
    • 12.4.2. Lozenges
    • 12.4.3. Powder
    • 12.4.4. Gummies
  • 12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
    • 12.5.1. Online Stores
    • 12.5.2. Pharmacies
    • 12.5.3. Supermarkets
    • 12.5.4. Others

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles
    • 13.3.1. Now Foods
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Product Portfolio/Offerings
      • 13.3.1.3. Key Financials
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Company Strategy and Key Developments
    • 13.3.2. Horbaach
    • 13.3.3. Pure Encapsulations
    • 13.3.4. Thorne
    • 13.3.5. Vitanica
    • 13.3.6. Nutrabio
    • 13.3.7. Country Life
    • 13.3.8. Integrative Therapeutics
    • 13.3.9. Solgar
    • 13.3.10. Nusa Pure

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!